Stavros Vizirgianakis's Insider Trades & SAST Disclosures
Stavros Vizirgianakis's most recent trade in Apyx Medical Corp was a trade of 128,000 Stock Option (Option to Buy) done . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stavros Vizirgianakis.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apyx Medical Corp | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 128,000 | 128,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 17,000 | 17,000 | - | - | Stock Option (Option to Buy) | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 16,648 | 16,648 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 965 | 1,930 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 965 | 2,781,888 (11%) | 0% | 0 | Class A common stock | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 2,780,923 | 2,780,923 (11%) | 11% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 347,323 | 347,323 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 261,794 | 261,794 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 89,001 | 89,001 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 34,905 | 34,905 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 26,179 | 26,179 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 19,634 | 19,634 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 6,544 | 6,544 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Stavros Vizirgianakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 2,895 | 2,895 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges